TRPM7 Gene

TRPM7 — Transient Receptor Potential Cation Channel Subfamily M Member 7

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TRPM7 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>TRPM7</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Transient Receptor Potential Cation Channel Subfamily M Member 7</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>15q21.3</td>
</tr>
<tr>
<td class="label">Gene ID</td>
<td>54822</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000156113</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q9BQZ6</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>CHAK1 (Channel Kinase 1), LTrpC7, TRP-PLK, MIC</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/autoimmune" style="color:#ef9a9a">Autoimmune</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/neuroinflammation" style="color:#ef9a9a">Neuroinflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">100 edges</a></td>
</tr>
</table>

Overview

TRPM7 — Transient Receptor Potential Cation Channel Subfamily M Member 7

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TRPM7 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>TRPM7</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Transient Receptor Potential Cation Channel Subfamily M Member 7</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>15q21.3</td>
</tr>
<tr>
<td class="label">Gene ID</td>
<td>54822</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000156113</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q9BQZ6</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>CHAK1 (Channel Kinase 1), LTrpC7, TRP-PLK, MIC</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/autoimmune" style="color:#ef9a9a">Autoimmune</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/neuroinflammation" style="color:#ef9a9a">Neuroinflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">100 edges</a></td>
</tr>
</table>

Overview

TRPM7 (Transient Receptor Potential Cation Channel Subfamily M Member 7) is a unique bifunctional protein that combines an ion channel with a serine/threonine kinase domain. This channel-kinase, often referred to as "chanzyme," is critical for cellular magnesium homeostasis, calcium signaling, and has emerged as an important player in neurodegeneration["@nadiri2014"]. Unlike most ion channels that are purely conductive proteins, TRPM7 possesses intrinsic enzymatic activity, making it a fascinating target for both basic neuroscience research and therapeutic development.

TRPM7 belongs to the melastatin subfamily of TRP (Transient Receptor Potential) channels, which includes TRPM1-8. The melastatin family is characterized by their expression in various tissues and involvement in diverse physiological processes. TRPM7 is distinguished by its dual functionality: the channel domain permits ion flux while the C-terminal kinase domain can phosphorylate downstream substrates.

Gene Information

Structure and Evolution

Genomic Organization

The TRPM7 gene spans approximately 70 kb on chromosome 15q21.3. The gene consists of 39 exons that encode a large protein of approximately 2035 amino acids. The coding sequence is highly conserved across vertebrates, reflecting the fundamental importance of TRPM7 in cellular physiology.

Protein Domain Architecture

TRPM7 possesses a distinctive dual-domain structure:

Channel Domain (N-terminal):

• Transient receptor potential domain: Six transmembrane segments (S1-S6) forming the ion conduction pore
• Porous region: Selectivity filter determining ion permeation properties
• Voltage sensor: S4 segment contributes to voltage-dependent gating

• Serine/threonine kinase core: Catalytic domain with typical kinase motifs
• Auto-regulatory region: Controls kinase activity through autophosphorylation
• Multiple phosphorylation sites: Regulatory serine and threonine residues

Normal Physiological Functions

Ion Channel Activity

TRPM7 functions as a non-selective cation channel with significant permeability to:

• Magnesium (Mg²⁺): Primary physiological substrate, essential for cellular metabolism
• Calcium (Ca²⁺): Important for signaling pathways and neuronal function
• Zinc (Zn²⁺): Trace element with signaling functions
• Other cations: Including sodium, potassium, and iron

Gating Mechanisms:

• Voltage-dependent activation: Membrane depolarization activates the channel
• Intracellular magnesium inhibition: Mg²⁺ acts as a potent channel blocker
• ATP sensitivity: Cellular energy status modulates channel activity
• pH sensitivity: Proton concentration affects channel function

Kinase Activity

The C-terminal serine/threonine kinase domain has enzymatic activity:

Autophosphorylation:

• The kinase can phosphorylate itself, regulating its own activity
• Autophosphorylation is calcium/calmodulin-dependent
• Kinase activity modulates channel function

• Phosphorylates multiple downstream targets
• Affects various cellular processes
• Links channel activity to signaling cascades

Cellular Functions

TRPM7 participates in numerous cellular processes:

Magnesium Homeostasis:

• Primary pathway for cellular magnesium uptake
• Essential for ATP-dependent reactions
• Regulates Mg²⁺-dependent enzymes

• Modulates intracellular calcium dynamics
• Affects calcium-dependent signaling pathways
• Participates in calcium homeostasis

• Required for cell cycle progression
• Affects cell survival and death decisions
• Important for embryonic development

• Promotes neurite outgrowth
• Affects dendritic branching
• Guides growth cone behavior

Expression Pattern

Tissue Distribution

TRPM7 is widely expressed throughout the body:

• Brain: High expression in hippocampus, cortex, cerebellum
• Heart: Cardiac muscle cells
• Skeletal muscle: Myocytes
• Kidney: Renal tubular cells
• Liver: Hepatocytes
• Immune cells: Lymphocytes, macrophages

Brain Expression

Within the central nervous system, TRPM7 is expressed in:

• Hippocampus: CA1 pyramidal neurons, dentate gyrus granule cells
• Cerebral cortex: Layer V pyramidal neurons, interneurons
• Cerebellum: Purkinje cells, granule cells
• Substantia nigra: Dopaminergic neurons
• Spinal cord: Motor neurons, interneurons

Subcellular Localization

In neurons, TRPM7 localizes to:

• Somatic membrane: Cell body plasma membrane
• Dendrites: Throughout dendritic arborization
• Dendritic spines: Postsynaptic compartments
• Axon initial segment: Action potential initiation zone
• Growth cones: During development and regeneration

Role in Alzheimer's Disease

Magnesium Dysregulation

TRPM7 dysfunction contributes to magnesium dysregulation in Alzheimer's disease[@sun2017]:

Cellular Magnesium:

• Neurons require tight magnesium regulation for normal function
• TRPM7-mediated magnesium uptake is impaired in AD
• Magnesium deficiency affects neuronal energy metabolism

• Magnesium is essential for ATP synthesis and utilization
• Impaired magnesium homeostasis affects cellular energetics
• Contributes to neuronal energy failure in AD

Calcium Homeostasis

Calcium dysregulation is a hallmark of AD, and TRPM7 contributes:

Calcium Signaling:

• TRPM7 affects intracellular calcium levels
• Altered calcium dynamics disrupt synaptic plasticity
• Contributes to excitotoxicity

• TRPM7 interacts with NMDA-type glutamate receptors
• Modulates calcium influx through NMDA receptors
• Contributes to calcium dysregulation in AD

Amyloid Effects

Amyloid-beta (Aβ) affects TRPM7 function:

• Direct interaction: Aβ can modulate TRPM7 channel activity
• Indirect effects: Aβ-induced signaling affects TRPM7
• Pathological outcomes: Contributes to synaptic dysfunction

Tau Pathology

TRPM7 kinase domain may influence tau pathology:

• Kinase activity: TRPM7 can phosphorylate various substrates
• Tau kinases: Links to tau phosphorylation pathways
• Aggregation: May affect tau aggregation mechanisms

Role in Parkinson's Disease

Dopaminergic Neuron Survival

TRPM7 plays critical roles in dopaminergic neuron survival in the substantia nigra[@zhou2019]:

Ion Homeostasis:

• TRPM7-mediated magnesium uptake is essential for neuronal health
• Calcium dysregulation contributes to dopaminergic neuron loss
• Maintains ionic balance for neuronal function

• Magnesium is a cofactor for many mitochondrial enzymes
• TRPM7 dysfunction affects mitochondrial energy production
• Contributes to the vulnerability of dopaminergic neurons

Alpha-Synuclein

TRPM7 may influence alpha-synuclein (α-syn) pathology:

• Aggregation pathways: Magnesium affects α-syn aggregation kinetics
• Cellular clearance: Autophagy-lysosome pathways are affected
• Intercellular transmission: May influence α-syn spreading

Oxidative Stress

Oxidative stress is a key feature of PD, and TRPM7 participates[@gao2022]:

Redox Signaling:

• TRPM7 is sensitive to oxidative stress
• Oxidative modifications affect channel function
• Contributes to redox signaling dysregulation

• TRPM7 affects cellular antioxidant systems
• Impaired function reduces neuroprotection
• Contributes to oxidative damage

Role in ALS and Other Disorders

Amyotrophic Lateral Sclerosis (ALS)

TRPM7 contributes to ALS pathogenesis:

Motor Neuron Vulnerability:

• High metabolic demand increases TRPM7 relevance
• Magnesium dysregulation affects motor neurons
• Calcium dysregulation contributes to excitotoxicity

• TRPM7 affects axonal transport
• Contributes to axonal degeneration
• Affects neuromuscular junction function

Multiple Sclerosis

TRPM7 may play roles in demyelination:

• Oligodendrocyte function: Myelin-producing cells require TRPM7
• Axonal degeneration: Common pathway in MS lesions
• Neuroprotection: Potential therapeutic target

Stroke and Brain Injury

In acute neurological injury:

• Ischemic damage: TRPM7 contributes to calcium dysregulation
• Excitotoxicity: Enhanced by TRPM7 dysfunction
• Potential for neuroprotection: Targeting TRPM7

Therapeutic Implications

Channel Modulators

Developing compounds that modulate TRPM7 channel activity:

Activators:

• Increase channel activity to enhance magnesium uptake
• May improve neuronal magnesium homeostasis
• Potential for AD and PD therapy

• Reduce excessive channel activity
• May protect against excitotoxicity
• Need brain-penetrant compounds

Kinase Inhibitors

Targeting the kinase domain:

Small Molecule Inhibitors:

• Inhibit pathological kinase activity
• May provide neuroprotection
• Must achieve brain penetration

• Avoiding off-target effects on other kinases
• Achieving sufficient potency
• Balancing channel and kinase modulation

Magnesium Supplementation

Addressing magnesium deficiency:

Dietary Approaches:

• Magnesium supplementation may help
• Limited CNS penetration is a challenge
• May support TRPM7 function

• Brain-penetrant magnesium compounds
• Combining with TRPM7 modulators

Combination Strategies

Given the complexity:

• Channel + kinase: Combined targeting
• Symptomatic + disease-modifying: Multi-target approaches
• Personalized medicine: Based on patient genetics

Research Directions

Key Questions

Several fundamental questions remain:

Research Tools

Advancing the field requires:

• Selective probes: Agonists and antagonists for research
• Genetic models: Transgenic and conditional knockouts
• Patient samples: Brain tissue and biomarkers
• Clinical studies: TRPM7 as a therapeutic target

Drug Development Challenges

Significant hurdles exist:

• Selectivity: Achieving specificity for TRPM7
• Brain penetration: Getting compounds to the CNS
• Efficacy: Demonstrating disease modification
• Safety: Avoiding off-target effects

Summary

TRPM7 is a unique bifunctional channel-kinase with critical roles in cellular magnesium and calcium homeostasis. Through its dual functions, TRPM7 contributes to neuronal physiology and participates in the pathogenesis of multiple neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and ALS.

The channel and kinase activities of TRPM7 make it an attractive therapeutic target. Developing modulators that can selectively affect TRPM7 function in the brain may provide new treatment options for these devastating diseases. However, significant research is needed to fully understand TRPM7's functions and develop effective, safe therapeutic approaches.

References

Pathway Diagram

The following diagram shows the key molecular relationships involving TRPM7 Gene discovered through SciDEX knowledge graph analysis: